| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9270792 | Journal of Infection | 2005 | 7 Pages |
Abstract
Conclusions. Subjects with HIV/HCV co-infection have a higher prevalence of diabetes and thus may need to be screened for it prior to initiation of anti-retroviral therapy, particularly if it is a PI based regimen.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Fehmida Visnegarwala, Li Chen, Subha Raghavan, Ellen Tedaldi,